MENU
WORLDALLERGY.ORG
Facebook: World Allergy Organization
Twitter: World Allergy Organization
LinkedIn: World Allergy Organization
Instagram: World Allergy Organization

International: Presentation Materials

Module 1: Allergic Rhinitis

PowerPoint Slides

The first GLORIA module focuses on allergic rhinitis and its link to allergic conjunctivitis.

Upon completion of this program, participants should be able to:

  • Describe the revised nomenclature for allergic rhinitis based on the ARIA document
  • Discuss the stepwise treatment of allergic rhinitis based on symptom severity
  • Recognize the relationship between allergic rhinitis and allergic conjunctivitis
  • Differentiate between the major allergic eye diseases
  • Describe the treatments available for allergic conjunctivitis

Slide content revised January 2009; slide format updated June 2011

Module 2: Allergic Conjunctivitis

PowerPoint Slides

This module concentrates more in-depth on stepwise diagnosis, treatment and pharmacotherapy of allergic conjunctivitis.

Upon completion of this program, participants should be able to:

  • Describe the major allergic eye diseases and their epidemiology
  • Discuss the differential diagnosis of allergic eye diseases
  • Explain the mode of action of allergic conjunctivitis therapies
  • Recommend a management plan for uncomplicated allergic conjunctivitis

Slide content revised January 2009; slide format updated June 2011

Module 3: Allergic Emergencies

PowerPoint Slides

The third module of GLORIA contains three sections, focusing on the emergency treatment of anaphylaxis, upper airway edema and status asthmaticus.

Upon completion of this program, participants should be able to:

  • Understand the different mechanisms which cause anaphylaxis and the agents which are most likely to cause it
  • Recognize the signs and symptoms of anaphylaxis
  • Understand the principles of the emergency treatment of anaphylaxis
  • Discuss the causes of angioedema
  • Review the spectrum and management of hereditary angioedema
  • Describe Angiotensin Converting Enzyme (ACE) inhibitor related angioedema
  • List the risk factors for asthma exacerbations
  • Identify the signs and symptoms of acute asthma
  • Outline appropriate treatment strategies for acute asthma

Slide content revised January 2009; slide format updated June 2011

Module 4: Immunotherapy

PowerPoint Slides

This evidence-based module provides an in-depth review of allergen immunotherapy, and reviews injection and local administration routes of immunotherapy. 

Upon completion of this program, participants should be able to:

  • Discuss the standardization of allergen extracts
  • List the efficacy, safety and long-term benefits of immunotherapy
  • Explain the mode of action of immunotherapy
  • Describe injection and non-injection methods of immunotherapy
  • Select suitable patients for immunotherapy

Slide content revised January 2009; slide format updated June 2011

Module 5: Treatment of Severe Asthma

PowerPoint Slides

The Treatment of Severe Asthma module investigates the pathophysiology, assessment and treatment of each symptom and sign of asthma.

Upon completion of this program, participants should be able to:

  • Describe the signs and symptoms of asthma and the underlying pathophysiology of each
  • Explain the current concepts of asthma treatment

Slide content revised January 2009; slide format updated June 2011

Module 6: Food Allergy

PowerPoint Slides

This module gives an extensive review of food allergy, from pathology and mechanisms of IgE-mediated and T-cell-mediated food allergy to diagnosis and clinical management.

Upon completion of this program, participants should be able to:

  • Recognize the main pathogenic food allergens in adults and children
  • Differentiate between IgE-mediated, cell-mediated and mixed IgE- and cell-mediated food-related diseases in different organ systems
  • Discuss the diagnosis of food allergy and the limitations of diagnostic techniques
  • Describe the treatment of food allergy

Slide content revised January 2009; slide format updated June 2011

Module 7: Angioedema

PowerPoint Slides

The Angioedema module reviews the pathophysiology, diagnosis, genetics and management of acquired and genetic forms of angioedema.

Upon completion of this program, participants should be able to:

  • Outline the major causes and differential diagnosis of angioedema and hereditary angioedema
  • Explain the treatment options for the management of hereditary and acquired angioedemas

Slide content revised June 2011

Module 8: Anaphylaxis

PowerPoint Slides

The module has been developed to provide a global overview on the pathophysiology, epidemiology, diagnosis and management of Anaphylaxis, a life-threatening allergic condition.

Upon completion of this program, participants should be able to:

  • Discuss the different mechanisms which underlie anaphylaxis and the agents most likely to cause it
  • Recognize the signs and symptoms of anaphylaxis
  • Describe the principles of the emergency treatment of anaphylaxis

Slide content revised January 2009; slide format updated June 2011

Module 9: Diagnosis of IgE Sensitization

PowerPoint Slides

This module reviews the specificity and sensitivity of the major diagnostic tests--skin testing and allergen-specific IgE antibody serology--that help to determine the pathological mechanisms underlying allergic symptoms.

Upon completion of this program, participants should be able to:

  • Recommend the appropriate clinical tests for diagnosing allergic diseases
  • Discuss the appropriate use of skin prick tests and serum tests in the diagnosis of IgE-mediated allergic diseases
  • Describe the interpretation of clinical history and false positive and false negative diagnostic tests
  • Discuss the use of allergy testing to measure response to allergen avoidance and immunotherapy

Slide content revised January 2009; slide format updated June 2011

Module 10: Chronic Rhinosinusitis and Nasal Polyposis

PowerPoint Slides

This extensive module reviews the anatomy and physiology of the nose and paranasal sinuses. The definition and different phenotypes of rhinosinusitis and its pathogenesis are described. Diagnosis, concomitant problems, and medical management are discussed.

Upon completion of this program, participants should be able to:

  • Understand the definition and different phenotypes of chronic rhinosinusitis
  • Have knowledge of its pathogenesis
  • Understand how to diagnose and treat rhinosinusitis

Slide content revised January 2009; slide format updated June 2011


Module 11: Drug Allergy

Slides (Part 1)    Slides (Part 2)

This 2 part slide set covers definitions, epidemiology, risk factors, clinical manifestations with reference to pathogenesis/mechanisms, specific classes of drugs, diagnosis, treatment, desensitization and prevention.

Upon completion of Part 1 of this program, participants should be able to:

  • Understand the difference between
    • Adverse drug reaction
    • Drug hypersensitivity
    • Drug allergy
  • Understand the epidemiology and risk factors for drug allergy
  • Understand the pathogenesis and immunological mechanisms underlying the different phenotypes of drug allergy

Upon completion of Part 2 of this program, participants should be able to:

  • Understand the clinical features of drug allergy in relation to the underlying pathogenetic mechanisms
  • Understand the principles in the clinical diagnosis of drug allergy
  • Understand the principles of diagnostic and provocation tests
  • Manage drug allergies

Slide content revised January 2009; slide format updated June 2011


Module 12: Urticaria

PowerPoint Slides

This module focuses on Urticaria, reviewing the classification, pathophysiology, diagnosis and treatment of physical, chronic idiopathic and chronic urticarias.

Upon completion of this program, participants should be able to:

  • Distinguish the various forms of physical urticaria
  • Formulate a differential diagnosis and treatment plan for acute urticaria
  • Describe the role of autoimmunity as a pathogenic mechanism for chronic urticaria
  • Describe a therapeutic approach for patients with severe chronic idiopathic or chronic autoimmune urticaria.
  • Distinguish urticarial vasculitis from other forms of chronic urticaria

Slide content revised January 2009; slide format updated June 2011



Last Updated: June 19, 2015